IP Library › Assignment 027655/0352
Patent Assignment
Reel/Frame 027655/0352

Change of Name

Recorded: 2012-02-06 Pages: 7
Assignor
SOLUPRIN PHARMACEUTICALS, INC.
Executed: 2012-01-26
Assignee
THEAPRIN PHARMACEUTICALS INC.
100 PARK AVENUE, SUITE1600, NEW YORK, NEW YORK, 10017
Covered Property (1)
Intravenous Formulation with Water-Soluble Cocrystals of Acetylsalicylic Acid and Theanine
Patent: 8,173,625 →
Application: 12/437,735 →
Publication: US 2010/0286099
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 12, 2009
From: BRITTAIN, PHD, HARRY G.; FELICE, M.D., PHILIP V.
To: SOLUPRIN PHARMACEUTICALS, INC.
Reel/Frame 022673/0701 →
Corrective Assignment to Correct the Address of the Assignee Previously Recorded on Reel 027655 Frame 0352. Assignor(S) Hereby Confirms the Assignment. Feb 8, 2012
From: SOLUPRIN PHARMACEUTICALS, INC.
To: THERAPRIN PHARMACEUTICALS INC.
Reel/Frame 027675/0408 →
Corrective Assignment to Correct the Assignee Name Previously Recorded on Reel 027675 Frame 0408. Assignor(S) Hereby Confirms the Corrective Assignment of a Change of Name. Apr 6, 2012
From: SOLUPRIN PHARMACEUTICALS, INC.
To: THEAPRIN PHARMACEUTICALS INC.
Reel/Frame 028003/0601 →